153 related articles for article (PubMed ID: 25775241)
1. Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.
Broome AM; Ramamurthy G; Lavik K; Liggett A; Kinstlinger I; Basilion J
Bioconjug Chem; 2015 Apr; 26(4):660-8. PubMed ID: 25775241
[TBL] [Abstract][Full Text] [Related]
2. Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging.
Kuijten MM; Hannah Degeling M; Chen JW; Wojtkiewicz G; Waterman P; Weissleder R; Azzi J; Nicolay K; Tannous BA
Sci Rep; 2015 Nov; 5():17220. PubMed ID: 26610702
[TBL] [Abstract][Full Text] [Related]
3. Biotinylated Bioluminescent Probe for Long Lasting Targeted in Vivo Imaging of Xenografted Brain Tumors in Mice.
Jiang YL; Zhu Y; Moore AB; Miller K; Broome AM
ACS Chem Neurosci; 2018 Jan; 9(1):100-106. PubMed ID: 28532151
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
[TBL] [Abstract][Full Text] [Related]
5. EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and streptavidin.
Jung KH; Park JW; Paik JY; Quach CH; Choe YS; Lee KH
Nucl Med Biol; 2012 Nov; 39(8):1122-7. PubMed ID: 22819251
[TBL] [Abstract][Full Text] [Related]
6. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
8. Imaging beta-galactosidase activity in vivo using sequential reporter-enzyme luminescence.
von Degenfeld G; Wehrman TS; Blau HM
Methods Mol Biol; 2009; 574():249-59. PubMed ID: 19685314
[TBL] [Abstract][Full Text] [Related]
9. Biotin-ligand complexes with streptavidin quantum dots for in vivo cell labeling of membrane receptors.
Lidke DS; Nagy P; Jovin TM; Arndt-Jovin DJ
Methods Mol Biol; 2007; 374():69-79. PubMed ID: 17237530
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
11. [Reporter genes transfer into human squamous cell carcinoma of larynx factor receptor mediated non-viral GE7 polypeptide delivery system with a new epidermal growth].
Xiao SF; Xi L; Zhou YD; Wang CY; Tian PK; Gu JR
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):283-7. PubMed ID: 15338866
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approach.
Chen J; Gamou S; Takayanagi A; Ohtake Y; Ohtsubo M; Shimizu N
Cancer Gene Ther; 1998; 5(6):357-64. PubMed ID: 9917090
[TBL] [Abstract][Full Text] [Related]
13. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting.
Scherpereel A; Wiewrodt R; Christofidou-Solomidou M; Gervais R; Murciano JC; Albelda SM; Muzykantov VR
FASEB J; 2001 Feb; 15(2):416-26. PubMed ID: 11156957
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy.
Jung KH; Choe YS; Paik JY; Lee KH
J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406
[TBL] [Abstract][Full Text] [Related]
16. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
17. Construction of an EGF receptor-mediated histone H1(0)-based gene delivery system.
Dai FH; Chen Y; Ren CC; Li JJ; Yao M; Han JS; Gong Y; Yang SL; Zhu JD; Gu JR
J Cancer Res Clin Oncol; 2003 Aug; 129(8):456-62. PubMed ID: 12884022
[TBL] [Abstract][Full Text] [Related]
18. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
[TBL] [Abstract][Full Text] [Related]
19. A sensitive fluorescent probe for β-galactosidase activity detection and application in ovarian tumor imaging.
Fan F; Zhang L; Zhou X; Mu F; Shi G
J Mater Chem B; 2021 Jan; 9(1):170-175. PubMed ID: 33230516
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]